Figure 1

LincRNAs associated with cisplatin resistance.
Toxicity analysis of cisplatin sensitive. (A2780) and resistant cells (A2780-DR) under cisplatin treatment (5, 10, 20 uM) in 24 hours; (B) Linc-RECK-3, H19, LUCAT1, LINC00961 and linc-CARS2-2 expression level in cisplatin sensitive and resistant cells; (C) Linc-TNFRSF19-1 and LINC00515 expression level in cisplatin sensitive and resistant cells; (D) Linc-RECK-3 expression level in different tissues and in different RFS patients samples; (E) H19 expression level in different tissues and different RFS patients samples.The statistic analysis of (D,E) was performed by t-test, two sided, equal variances not assumed.